Abstract. Ganglioside storage diseases are inherited defects of lysosomal hydrolases that result in intralysosomal accumulation of gangliosides and other complex metabolites. Gangliosidoses occur in man, cats, cattle, dogs and swine. In all species, these diseases are characterized clinically by relentlessly progressive neurological deterioration. Lysosomal hypertrophy with characteristic ultrastructural inclusions occur in neurons, endothelial and other cells. Definitive diagnosis requires biochemical identification of the storage product and enzyme deficiency. Gangliosidoses in animals are important models of human lysosomal diseases and may be a significant complication in the maintenance of certain purebred stocks of domestic animals.According to current concepts, the lysosomal system is the principal site of intracellular digestion and consists of membrane-bound cytoplasmic organelles containing more than 40 acid hydrolases capable of degrading most biologically important macromolecules. Mutations that cause reduced hydrolytic activity of lysosomal hydrolases result in diseases characterized by incomplete catabolism and concomitant accumulation ("storage") of undergraded substrate within lysosomes [7, 9, 181. The gangliosidoses are lysosomal diseases resulting from incomplete catabolism and intralysosomal accumulation of gangliosides and related complex glycolipids and glycoproteins. These diseases have been recognized in five mammalian species including man, cats, cattle, dogs and swine (31. Regardless of species affected, the gangliosidoses are characterized by 1) progressive nervous system deterioration that usually begins early in life and ultimately leads to premature death; 2) autosomal recessive inheritance; 3) lysosomal hypertrophy in neurons, hepatocytes, macrophages and other cells resulting from deposition of glycoproteins or glycolipids; and 4) absence or marked reduction in activity of specific lysosomal enzymes required for hydrolysis of accumulated compounds.Most lysosomal storage diseases, including the gangliosidoses, are untreatable. Furthermore, the pathogenesis of cell injury and death resulting from lysosomal hypertrophy remains obscure. Therefore, animal models of these diseases are of critical importance for progress in basic and applied research. Also, it is becoming 635